Reverse Transcriptase Polymerase Chain Reaction: Clinical Trials

98 trials of Reverse Transcriptase Polymerase Chain Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed, 14 terminated, 10 unknown, 6 withdrawn. 21 Phase 2, 20 Phase 1, 7 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 221Completed 13, Terminated 8
Phase 120Completed 12, Terminated 6, Withdrawn 2
Not applicable7Completed 6, Unknown 1
Early Phase 11Withdrawn 1

Follow Reverse Transcriptase Polymerase Chain Reaction: new trials by email Literature Review of Reverse Transcriptase Polymerase Chain Reaction trials Research Report on Reverse Transcriptase Polymerase Chain Reaction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers
The retrospective analyses planned for these samples consist of serological analysis and molecular analysis (RT-PCR ) according to the date of symptoms ons - Arbovirus Infections
Active not recruitingUniversity Hospital, Strasbourg, France2002025-08-012025-08-08
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
Vaginal swab for RT-PCR, Vaginal swab for culture, Metabolic gas signatures detected by Ainos Flora (operated by participant) - Vaginal Infection, Vaginitis
Not applicableUnknownTaiwan Carbon Nano Technology Corporation1202022-10-082024-04-10
MSCT Chest in Suspected COVID-19 Patients
MSCT - COVID-19
UnknownAssiut University1502020-07-302020-07-30
Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center
Screening test for covid ( RT PCR and CT Chest) - Digestive Cancer, Gynaecological Cancer
CompletedHospices Civils de Lyon1122020-03-192020-05-07
Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B
Respirio Flu Test, eLab Flu Test, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) - Influenza A, Influenza B
Not applicableCompletedEllume Pty Ltd15002016-07-012016-12-06
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
Respirio Flu Test, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), Sofia® Influenza A+B Fluorescent Immunoassay (FIA) - Influenza A, Influenza B
Not applicableCompletedEllume Pty Ltd832015-09-012016-07-15
The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou602013-06-012015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou602013-06-012015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou602013-06-012015-12-30
The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou802013-06-012015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou602013-06-012015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou602013-06-012015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Flow cytometry (FCM), RT-PCR - Neoplastic Cells, Circulating
CompletedFuda Cancer Hospital, Guangzhou1202013-06-012016-02-25
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
cholecalciferol, biopsy, protein expression analysis - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Early Phase 1WithdrawnCase Comprehensive Cancer Center2012-04-012014-01-17
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
RNA analysis, gene expression analysis, mutation analysis - Childhood Germ Cell Tumor, Leydig Cell Tumor
CompletedChildren's Oncology Group502012-04-012016-07-14
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
RNA analysis, reverse transcriptase-polymerase chain reaction, laboratory biomarker analysis - Leukemia
CompletedChildren's Oncology Group602012-02-012016-05-17
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
gene expression analysis, proteomic profiling, reverse transcriptase-polymerase chain reaction - Kidney Cancer
CompletedChildren's Oncology Group202012-02-012016-05-18
Biomarkers in Patients With Rhabdomyosarcoma
DNA methylation analysis, fluorescence in situ hybridization, gene expression analysis - Sarcoma
CompletedChildren's Oncology Group202011-10-012016-05-19
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
RNA analysis, gene expression analysis, microarray analysis - Breast Cancer
UnknownNSABP Foundation Inc13002011-10-012015-05-08
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Hsp90 inhibitor STA-9090, laboratory biomarker analysis, polymerase chain reaction - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer
Phase 2CompletedBarbara Ann Karmanos Cancer Institute182011-01-012018-09-18

Showing 20 of 98. Sign in to see all of them.

Conditions studied

Leukemia (17)  ·  Breast Neoplasms (14)  ·  Colonic Neoplasms (7)  ·  Colorectal Neoplasms (7)  ·  Leukemia, Myeloid, Acute (7)  ·  Lung Neoplasms (7)  ·  Neoplastic Cells, Circulating (7)  ·  Rectal Neoplasms (7)  ·  Head and Neck Neoplasms (6)  ·  Prostatic Neoplasms (6)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Kidney Neoplasms (5)  ·  Congenital Abnormalities (4)  ·  Multiple Myeloma (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)

Sponsors

Children's Oncology Group (13)  ·  City of Hope Medical Center (9)  ·  Fuda Cancer Hospital, Guangzhou (7)  ·  Alliance for Clinical Trials in Oncology (6)  ·  Case Comprehensive Cancer Center (5)  ·  Mayo Clinic (4)  ·  Roswell Park Cancer Institute (4)  ·  ECOG-ACRIN Cancer Research Group (3)  ·  Barbara Ann Karmanos Cancer Institute (2)  ·  Eastern Cooperative Oncology Group (2)  ·  Ellume Pty Ltd (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Gynecologic Oncology Group (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  NSABP Foundation Inc (2)

Countries

United States (48)  ·  China (7)  ·  Australia (2)  ·  Belgium (2)  ·  France (2)  ·  Canada (1)  ·  Egypt (1)  ·  Ireland (1)  ·  Taiwan (1)

Top investigators

Abeer Ali, M D (1)  ·  Afshin Dowlati, MD (1)  ·  Ahmad Awada, MD, PhD (1)  ·  Ambika Babu, MD (1)  ·  Amy Heerema-McKenney, MD (1)  ·  Angela Davies, MD (1)  ·  Anthony Stein, MD (1)  ·  Antonio Omuro, MD (1)  ·  Arjun Pennathur, MD (1)  ·  Asher Chanan-Khan (1)  ·  Bach Ardalan, MD (1)  ·  Balazs Halmos, MD (1)  ·  Barbara Murphy, MD (1)  ·  Bernardine McKellar (1)  ·  Bhaumik B. Patel, MD (1)

Results publications

PMID 11882819, PMID 14654545, PMID 15829324, PMID 18090584, PMID 18799354, PMID 20169594, PMID 20442368, PMID 21258083, PMID 22989664, PMID 23243055, PMID 23447365, PMID 24099865, PMID 24383844, PMID 24708709, PMID 25527568, PMID 26774555, PMID 27217450, PMID 31375516, PMID 34162404, PMID 34847232, PMID 35135810, PMID 36823396, PMID 37196637, PMID 38017103, PMID 38702786, PMID 39283025

NIH funding

P30CA033572 (6), P30CA015083 (3), U10CA031946 (3), P30CA008748 (2), P30CA036727 (2), P30CA043703 (2), P30CA068485 (2), U10CA032102 (2), P01HL048546 (1), P30CA016086 (1), P30CA023074 (1), P30CA072720 (1), P30CA093373 (1), P50CA091956 (1), P50CA107399 (1)